Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
|
CN |
|
S
|
Supreme Electronics Co Ltd
TWSE:8112
|
TW |
|
I
|
ING Bank Slaski SA
WSE:ING
|
PL |
|
Annehem Fastigheter AB (publ)
STO:ANNE B
|
SE |
|
K
|
Kothari Products Ltd
NSE:KOTHARIPRO
|
IN |
|
Nurol Gayrimenkul Yatirim Ortakligi AS
IST:NUGYO.E
|
TR |
|
H
|
House Foods Group Inc
TSE:2810
|
JP |
|
I
|
Investment Friends SE
WSE:IFR
|
EE |
|
Shinsegae International Inc
KRX:031430
|
KR |
|
A Plus Asset Advisor Co Ltd
KRX:244920
|
KR |
|
S
|
Suzhou Novosense Microlectronics Co Ltd
SSE:688052
|
CN |
|
O
|
Overseas Shipholding Group Inc
F:19O
|
US |
Bankruptcy Probability
Hubei Guangji Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hubei Guangji Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
|
2.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hubei Guangji Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hubei Guangji Pharmaceutical Co Ltd has total debt of 1.2B CNY. This includes both short-term (775.6m CNY) and long-term (462.2m CNY) debt.
You can find a full breakdown on its Balance Sheet.
